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1. Introduction 
Varicose veins are a common disorder and occur in about 40% of men and 32% of women. 
However the prevalence of the varicose veins has variability according to the age, gender, 
duration of reflux, and localization (superficial and/or deep veins). According to the Bonn 
Vein Study according to the duration of reflux (>500 ms) prevalence of the varicose veins in 
all veins was 35.3% (superficial veins: 21.0%, deep veins: 20.0%). The effect of venous 
insufficiency on patients’ quality of life is comparable with other common chronic diseases 
such as arthritis, diabetes and cardiovascular disease. (1, 2) 
Traditional treatment of great saphenous vein (GSV) varicosities includes ligation of the 
sapheno-femoral junction (SFJ) combined with GSV stripping (complete/partial). (3) For the 
small saphenous vein (SSV) and the perforator veins, situation is a little more complicated. 
Due to their anatomic challenges and variations, surgery for the SSV and the incompetent 
perforator veins is sometimes very difficult and may cause adverse events and 
complications.  
Conventional surgery for SSV incompetence presents a high incidence of recurrence (up to 
52% at 3 years) and is frequently associated with neurovascular injury. (4) In many instances 
this is the result of inaccurate ligation of saphenopopliteal junction (SPJ). Even in 
experienced hands saphenopopliteal ligation is not always technically successful. This is 
mainly due to the diverse anatomic anomalies of the SPJ and its proximity to the tibial and 
sural nerves. (5) Unlike the saphenofemoral junction of GSV which is almost constant, the 
SPJ is variable in terms of level, site of implantation into the popliteal vein, as well as 
termination and tributaries. (6) Rashid et al. (7) have shown that ligation of the SPJ is not 
achieved in 30% of the cases, even if the junction is marked pre-operatively under 
ultrasound guidance. The incision made in the popliteal fossa is associated with wound 
healing problems and infection in 19-23% of cases. (5) 
Incompetent perforator veins (IPVs) are also a significant source of venous hypertension 
and it is important to treat IPVs. (8) Traditional methods such as Linton procedure and the 
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modifications have a relatively high incidence of wound complications ranging from 20% to 
40%. (9) These procedures require general or regional anesthesia and involve a hospital stay 
of 3-5 days. Postoperative pain significant and may require narcotics. Subfacial endoscopic 
perforator surgery (SEPS) overcomes some of Linton’s limitations but have some of its own. 
(10) Percutaneous ablation of IPVs by using laser energy is a relatively new technique and 
has been performed very recently. 
Associated morbidity and patient dissatisfaction associated with the traditional surgical 
treatment have led to the development of alternative techniques. (3) Endovenous treatment 
modalities (laser ablation, radiofrequency ablation, steam, and foam sclerotherapy) have 
been readily accepted by both patients and doctors.  
2. Historical background 
Endovenous laser ablation (EVLA) of the GSV was first described by Puglisi (11) in 1989 in 
the International Union of Phlebology and the first successful results were reported by 
Navarro (12) in 2001. Although no multicenter clinical trials of the safety and efficacy of this 
procedure in humans have been published, many case series and some analysis of 
pathophysiological effects have been published subsequently.  
Endovenous laser treatment of GSV was approved by FDA in 2002 and SSV was approved 
in 2003. (13, 14) However, percutanous laser treatment of IPVs is a very new procedure. 
Proebstle (15) published early results of this procedure in 2007.  
3. Technological issues 
Lots of manufacturers produce laser generators, all of which seems to be effective in the 
thermal ablation of the incompetent varicose veins.  
Semiconductor (diode) lasers have been the main laser type employed for this treatment 
although some reports have mentioned the neodymium: yttrium-aluminium-garnet 
(Nd:YAG) laser. Laser wavelengths reported include 810nm, 940nm, 980nm, 1064nm, 1320 
nm and 1470 nm. (3, 16) 
Clinical trial experience with diode lasers has produced extremely low rates of deep vein 
thrombosis (DVT) and paraesthesia, a low risk of skin burns, and no documented cases of 
pulmonary embolism; both paraesthesia and skin burns have been associated with 1064 nm 
laser treatment. The most common side effects seen with all laser types are bruising, 
localised pain, induration and discomfort along the treated vein, and superficial phlebitis. 
(17) Longer wavelengths (>1000nm) show greater water absorption but are overall less 
strongly absorbed in blood than shorter wavelengths and may have some advantages for 
endovenous laser ablation. (18-20) The 1470 nm diode laser operates at a relatively new 
wavelength for this treatment and has been in use since 2006. (16) 
There has also been progress in the field of laser fibers (Figure 1). Recently, new fibre tips 
(jacket-tip fibres, glass, metal, ceramic, diffusion, radial, and tulip) were developed. There 
are promising results with radial laser fibers. (21) These new generation fibers also more 
echogenic than the old bare-tip fibers and can easily be seen on Doppler ultrasound. 
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Fig. 1. Picture of bare-tip and radial laser fibers. 
With the evolving technology, nowadays it is very difficult to follow technologic advances 
in the field of endovenous treatment modalities. However, we believe that in the near future 
technologic advances will overcome all the limitations of these procedures and endovenous 
procedures will definitely take the place of traditional surgical methods in the treatment of 
venous insufficiency. 
4. Patient selection 
Inclusion criteria consist of symptoms and signs of venous insuffiency. Any patient that has the 
indication for treatment of varicose veins can be treated by endovenous laser ablation method.  
In our clinical experience, we perform EVLA for patients other than absolute 
contrindications (22) (arteriovenous malformation, deep vein thrombosis and restricted 
immobility). Although there are some relative contraindications (22) documented in the 
literature such as deep vein reflux, previous treatment, large-vein diameter, anticoagulant 
therapy, hormone replacement therapy, tortuos vein, and aneurysmal vein segments, in our 
clinical practice we perform EVLA to all these patients with our increasing clinical 
experience. In our clinical experience deep vein reflux (less than 6 seconds) without 
extremity diameter increase (more than 3 cm) is not a contraindication for EVLA. 
EVLA may also be performed in patients not really suitable for surgical therapies. Such 
patients are patients taking anticoagulant therapy for various reasons (i.e. atrial fibrillation, 
mechanical valve prosthesis etc.). Those patients can be treated with EVLA without 
cessation of anticoagulation. In a study, Theivacumar et al. (23) evaluated the effects of 
Coumadin usage on surgical outcomes and recanalization rates. They reported no major 
complication and a slight difference in recanalization rate in Coumadin group. 
Presence of very tortuous or dilated veins does not prevent endovenous laser ablation. 
Besides the new laser fibers (such as radial fibers) and the longer wavelengths (1320 nm and 
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1470 nm), tumescent anesthesia and Trendelenburg position during the ablation procedures 
make endovenous laser ablation procedure possible for even the most dilated veins by 
shrinkage and circumferential ablation of the vein. It is sometimes difficult to advance the 
laser fiber in very tortuous veins. Skin stretching and positioning the vein sometimes help to 
advance the laser fiber. However, a second vein puncture may be necessary to complete the 
whole segment ablation of the diseased vein. By help of these techniques, we can simply say 
that almost every vein can be treated by EVLA. 
Another problematic issue is the veins that are located very subdermally. Laser ablation of 
this vein is not a problem. However at the postoperative period patients may feel the 
presence of these ablated veins as a palpable cord just under the skin and may also feel 
stretching. Sometimes those veins may cause hyperpigmentation in the long-term period. In 
order to prevent these negative effects such subdermal veins may be ablated until the end of 
the deeper part and the superficial subdermal part may be removed surgically. 
5. Procedure and technique 
Endovenous laser ablation of the varicose veins may be divided into four sections: 
1. Anesthesia regimen 
2. Vein puncture and positioning the laser fiber 
3. Ablation procedure 
4. Postoperative care 
5.1 Anesthesia regimen 
It is possible to perform EVLA under any kind of anesthesia; however it is contrary to the 
nature of this minimal invasive procedure to perform under general or spinal anesthesia. 
Tumescent local anesthesia is sufficient for this procedure. If concomitant phlebectomies are 
performed, additional local anesthesia is applied to the area of varicosities. Tumescent local 
anesthesia should be applied under ultrasound control into the interfascial space around the 
saphenous vein. If correctly applied, tumescent anesthia forms a heat shield around the vein 
and protects the perivascular tissues (i.e. nerves) and the skin from the high temperatures 
caused by the laser energy. The temperature at the tip of the laser fibre may reach 720 ºC 
and although tumescent anaesthesia reduces heat transfer to adjacent tissue irreversible 
nerve injury may occur at temperatures above 45 ºC. In a previous study measurements 
adjacent to the GSV have confirmed that following adequate infiltration of tumescent 
anaesthesia the perivenous temperature reaches a median of 34.5 ºC and thus nerve injury 
should be avoided. (24) This is particularly important when treating SSVs which is very 
close to the diffent nerves (posterior femoral nevre, tibial nerve, common peroneal nerve 
and sural nerve) due to its anatomic course. The authors recently published their experience 
for the importance of puncture site selection in the prevention of postoperative nerve 
injuries following SSV EVLA. (24) Different mixtures of solutions have been reported for 
tumescent anesthia. Either lidocaine or prilocaine are suitable in concentrations between 
0.05 and 0.2%. In our clinical experience we prefer to use the following mixture: 1000 ml 
saline 0.9%, 50 ml lidocaine 2%, 1 ml Epinenephrine 1:1000,10 mEq NaHCO3. A total 
volume of 100-500 cc is given according to length of the vein is reported in the literature. We 
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use a simple formula for the amount of tumescent anesthesia and give an amout of 10 
ml/treated vein centimeter. There are different techniques for administering tumescent 
anesthesia. But according to authors' experience, injection of the solution by the help of a 
motor pump is an easy method. However, if this is not avaliable then the solution can be 
injected via syringes under the ultrasound guidance. 
5.2 Vein puncture and positioning the laser fiber 
For a successful vein puncture there are some important rules. There should be a 
comfortable temperature in the surgical suit. Cold environment may cause vein spasm 
especially in sensitive patients. Patient also should be positioned in the reverse 
Trendelenburg position in order to fill the vein. Then the patient is cleaned. The ultrasound 
probe covered sterile and taken into the operating field. To preserve the minimal invasive 
nature of the procedure vein should be punctured percutaneously under ultrasound 
guidance. In the experienced hands it very easy to cannulate the vein percutaneously. Until 
gaining experience in the percutaneous cannulation, biopsy apparatus of Doppler probes 
may help to ease your cannulation. However if this is not possible, vein access can be done 
via stab incision and hooking of the saphenous vein. 
After gaining access to the vein, a guide-wire inserted (Figure 2) through the needle and 5 or 
6-F introducer sheath was placed over the guide-wire into the GSV. If a radial laser fiber is  
 
Fig. 2. Guide-wire in the sapheonus vein. 
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used a short guide-wire and short introducer is enough to advance the fiber in GSV. 
However if it is preferred to use a bare-tip fiber, long guide-wires and sheaths must be used. 
Regardless the type of the used laser fiber, fiber is advanced till a safe distance from the 
saphenofemoral junction (SFJ) under the ultrasound guidance. This distance is changing in 
the published literature between 1-2 cm and 3-4 cm. In our experience, with 980 nm and 
bare-tip laser fiber we keep the distance 1-2 cm below SFJ. However we can go up till 0.5-1 
cm below the SFJ with 1470 nm and radial laser fiber (Figure 3). For SSV ablation the 
distance from the saphenopopliteal junction should be decided according to the connection 
place and type of the SSV with popliteal vein. According to classification by Kosinski and 
Creton, SSV connects to the popliteal vein in very different types. (6) And incidence of nerve 
injury increase as the saphenopopliteal junction goes up to the popliteal crease. Usually as a 
simple rule at least a 2 cm distance should be kept between saphenopopliteal junction and 
the fiber for positioning. 
 
Fig. 3. Radial fiber in the saphenofemoral junction. 
Sometimes it is difficult to advance the fiber in tortuous veins. Usually straightening of the 
leg or guiding the fiber by external manipulation and compression may solve the problem. 
If these maneuvers do not solve the problem a second puncture of the above the impeded 
vein segment is necessary to achieve a complete ablation.  
The correct positioning of the fiber (just inferior to the entrance of the superficial epigastric 
vein into the GSV for GSV treatment and just inferior to the deep penetration of the SSV) is a 
very important step which must be done very cautiously to prevent any adverse event 
related with the procedure. The position must also be confirmed after injection of tumescent 
anesthesia, just before the beginning of the ablation (Figure 4). Since the echogenity of the 
bare-tip fibers is not so good, it needs good ultrasound skills and experience. Especially after 
the injection of tumescent solution, it is sometimes difficult to see the fiber due to the 
confounding effect of the solution. The radial fiber is more Doppler friendly and can also be 
seen easily after tumescent solution. (Figure 5) 
www.intechopen.com
 Endovenous Laser Treatment of Incompetent Superficial and Perforator Veins 
 
137 
 
 
Fig. 4. Control of the position of laser fiber at the saphenofemoral junction. 
 
 
Fig. 5. View of radial fiber after tumescent local anesthesic solution. 
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5.3 Ablation procedure 
After confirming the correct position of the fiber, patient is placed in Trendelenburg position 
to further empty the vein. This is especially important in treating the dilated veins.  
Ablation procedure may be performed in a pulsed or continuous fashion. In our experience 
we prefer continuous method. (Figure 6, 7) The fiber and/or sheath are withdrawn at a 
speed of 1-3 mm per second. This speed is determined by the given energy to treated vein 
centimeter. This is called as Linear Endovenous Energy Density (LEED). Generally 60-100 
J/cm LEED is delivered to the vein wall according to the diameter of the treated vein. 
Withdrawal speed should be a little slower at the proximal part than the distal part. During 
the withdrawal of the fiber, external hand compression over the ablated vein segment may 
help ever further narrowing the vein wall for increasing the vein wall laser energy 
interaction. Our goal is to achieve successful ablation while minimizing the rate of adverse 
events such as pain and bruising. 
 
 
 
 
 
Fig. 6. Beginning of the laser ablation at the safenofemoral junction. 
On the conclusion of the ablation procedure immediate Doppler confirmation is crucial. 
(Figure 8) Patencies of the deep veins (femoral vein, popliteal vein) as well as occlusion of 
the treated saphenous veins are recorded. 
www.intechopen.com
 Endovenous Laser Treatment of Incompetent Superficial and Perforator Veins 
 
139 
 
 
Fig. 7. Ablation at the midpart of great saphenous vein. 
 
   
                                       (a)                                                                            (b) 
Fig. 8. Picture showing the saphenofemoral junction preoperative (a) and immediate (b) 
after the procedure. 
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EVLA for incompetent perforator veins (IPVs) is a more demanding procedure when 
compared to GSV and SSV ablation. The key point in the EVLA of perforator vein is the vein 
access. Patient is placed in a reverse Trendelenburg position and a direct puncture is made 
under ultrasound guidance with a 21 Gauge micropuncture needle or 16 Gauge  
angiocatheteter. There is no specific catheter or fiber system for treating perforator veins. 
However, 400µm, 600 µm fibers can be used. Recently, Biolitec Company introduced a 200 
µm slim radial fiber for the treatment of IPVs. After gaining access, confirmation is 
performed by aspiration of the blood. Then the laser fiber should be positioned at the fascia 
level. Following the confirmation of the correct position, tumescent local anesthesia is 
administered around the vein. Then energy is applied to the vein. External compression 
with ultrasound probe may help to increase vein wall the contact. In our clinical experience, 
while treating IPVs we do not use continuous pull back, rather we prefer pulsed mode. 
Since there are conflicting results and high recanalization rates in the literature, we prefer to 
ablate every vein segment twice and to treat the possible longest vein segment. (8) After 
completion of laser ablation a compression should be applied over the vein for several 
minutes. Following the compression, confirmation of the occlusion of the vein is made with 
ultrasound and recorded. 
5.4 Postoperative care 
After the completion of the ablation procedure, patients should be placed on compression 
therapy. There are different compression therapy protocols in the literature. In our clinical 
experience, we have two different policies which are determined by the applied procedure. 
In the patient that we performed concomitant extensive phlebectomies, we use the external 
compression bandages (short-stretch) for the following 24 hours and then we use 23-32 
mmHg compression stockings (thigh high) for the following 4 weeks. If we do not perform 
concomitant phlebectomies, we directly use compression stockings for the following 4 
weeks. There are different conflicting recommendations about the duration and the need for 
the postoperative compression therapy. In a preliminary study by Berland et al., (26) it was 
reported that no detrimental effect was shown with the absence of post-procedural 
compression therapy. 
In the earlier studies low molecular weight heparin was recommended for the 8days 
following the procedure. In the beginning of our experience we also used this protocol. 
However after gaining experience, we do not use low molecular weight heparin in our 
patients excluding patients with obesity and older age. We use non steroid antiinflamatory 
drugs (i.e. diclofenac potassium, 75 mg, bid, p.o.), if necessary. Patients are advised to walk 
regularly during recovery from treatment. 
6. Follow-up 
Since there is the possibility of recanalization and/or incomplete ablation, patients should 
be controlled at appropriate intervals with physical examination and color-flow Doppler 
ultrasound. In the physical examination, any recurrent and/or new refluxing tributaries are 
recorded. Any signs or symptoms related with chronic venous insufficiency are also 
recorded. With the color-flow Doppler ultrasound occlusion of the ablated vein is examined. 
In our clinical protocol patients are seen at 1st week, 1st month, 3rd month, 6th month, 1st year 
and yearly thereafter. (Figure 9) 
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(d) 
Fig. 9. Postoperative follow-up doppler images of the same patients postoperative 1st day 
(a), postoperative 1st month (b) 6th month (c), 2nd year (d) 
7. Complications 
Complications of EVLA may be divided as procedure related and post-procedural events. 
Procedure related complications are generally related with technical difficulties. These are 
vein access and fiber advancement problems. As mentioned above warm and comfortable 
operating rooms may solve the problems related with venospasm. Also determining the 
most suitable place for puncture by Doppler ultrasound is important. A straight and 
appropriate size vein segment usually solves the problem. 
Postoperative bruising, pain, paresthesia, and induration are the most common adverse 
events. However, there are also other adverse events such as superficial thrombophlebitis, 
skin burn, deep vein thrombosis, infection, arteriovenous fistula and skin burn. Although 
these later adverse events are literally possible, they are uncommon. (16) 
Bruising is generally minimal and self-limiting and usually lasts less than two weeks period. 
(Figure 10) There are different rates of bruising in the literature (between 11-100%). (26) 
Bruising rates are higher with wavelengths that use hemoglobin as cromophore such as 810 
nm and 980 nm. However, Laser systems with emission wavelengths of 1320 nm and 1470 
nm have their main absorption in water. There are reduced postoperative pain and bruising 
with 1320 nm when compared to shorter wavelengths. In our previous randomized study, 
we compared 1470 nm with 980 nm for early postoperative adverse events and found that 
1470 nm wavelength was superior with reduced postoperative pain, bruising, and 
paresthesia. Furthermore patient satisfaction was also higher with 1470 nm. (27) 
Incidence of postoperative paresthesia is reported between 7 and 9.5%. Paresthesia is also 
mild and usually resolves average an 8 week period. It is mainly seen following the full 
length ablation of the GSV. However the situation is different for SSV which has very close 
relationship with nerves along with its anatomic course. In some studies temporary 
paraesthesia is reported as frequently as in 40% of limbs following the EVLA for the SSV. 
(25) In our clinical experience, incidence of paresthesia following EVLA for GSV with 1470 
nm is very low (1/54 limbs). The incidence may be reduced with partial (over the knee) 
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Fig. 10. Postoperative bruising. (980 nm and bare-tip fibre) 
ablation and accurate administered perivenous tumescent local anesthesia. In another study, 
we compared the postoperative nerve injury following SSV EVLA. Puncture site from the 
midcalf level was shown to decrease the paresthesia. (25). 
Indurations happen along the treated veins after EVLA that resembles either a palpable cord 
or the feeling of a shortened muscle at the medial part of the thigh. According to our study 
induration is more common with bare tip fibers, shorter wavelengths (i.e. 810nm, 980 nm), 
and higher LEED levels. Since they ablated the vein only the places that they contact the 
vein wall, bare tip fibers especially at the higher LEEDs may perforate the vein and 
extravasation of the leukocytes cause pain and the induration. Nowadays with use of radial 
fibers, longer wavelengths (such as 1470 nm), and lower LEED levels, the incidence of 
induration decreased dramatically. (28) 
Skin burn is vey rare complication. In the literature excluding the study by Chang et al. (29) 
in which no tumescent anesthesia was used, only nine cases of burns have been reported; 
two occured when no local anesthetic was used and two during treatment of tributaries. 
This situation emphasizes the importance of tumescent local anesthesia, especially in the 
very superficial veins. In our experience, we have never seen skin burns. 
Infection is very rare complication. However, there is a case report of septic 
thrombophlebitis following EVLA. (30) With adequate sterile technique infection is avoided. 
Skin burn is also a rare complication. This can be avoided by scrupulous technique plus 
injection of correct and adequate amount of tumescent local anesthesia. We have never seen 
infection and skin burn related with the EVLA procedure so far. 
Although it is rare, deep vein thrombosis is the most severe complication. In our experience 
no deep vein thrombosis was recorded so far. Endotermal Heat Induced Thrombosis (EHIT) 
(Regardless of the energy, either laser or radiofrequency) is now used for the propagation of 
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thrombus in to the deep system as a new terminology. (Table 1) EHIT II is considered to be 
significant, since it is a precursor to deep vein thrombosis. In a study by Sadek et al. 
incidence of EHIT II in patients treated with endovenous laser and radiofrequency was 
evaluated. They concluded that there was no significant difference between laser and 
radiofrequency for the incidence of EHIT II, and upon identification it should be treated 
using anticoagulation. (31) 
Hyperpigmentation along the ablated vein occurs in up to 12% patients, although most 
authors report a much lower incidence. It usually improves in time. (27) 
 
I 
II 
III 
IV 
Thrombosis to the level of the saphenofemoral (SF) junction 
Extension into the deep venous system, cross-sectional area ≤50% 
Extension into the deep venous system, cross-sectional area ≥50% 
Occlusion of the femoral vein 
Table 1. Endotermal Heat Induced Thrombosis (EHIT) classes (30) 
Complications related with the laser ablation of the incompetent perforator veins are also 
similar with great/small saphenous veins such as skin injury, nerve injury and deep vessel 
injury. However there is no clear data about the prevalence of these complications due to 
the limited number of studies with limited patient volumes. In one study, redness, 
numbness or blistering was reported as complication. (8) 
8. Outcomes 
Since the first publication of Navarro et al. in 2001, (12) many authors reported their 
experience on different wavelengths, fibers and veins. Also Van den Bos et al. (3) published 
the first review of endovenous therapies of lower extremity varicosities in 2009. There are 
almost similar results with successful ablation and low adverse events rates. Some of the 
studies and their results are summarized in Table 2. 
In some studies EVLA was compared to surgical stripping. Especially in the randomized 
trials, it was suggested that abolition of GSV reflux, improvements in quality of life, patient 
satisfaction and cosmetics are similar for both treatment modality. Although pain levels 
appear similar in both techniques, return to normal activity or work was reported earlier 
after EVLA. (3) 
Importance of wavelength is also matter of question. There is not so much data regarding 
the effects of wavelengths that can be used for a decision-making tool for the treatment of 
varicose veins. Proebstle et al. (19) compared 1320 nm Nd:YAG laser with 940 nm diode 
laser and concluded that endovenous laser treatment using a 1320 nm Nd:YAG laser causes 
fewer side effects compared with 940 nm diode laser. In our randomized clinical study we 
compared the 1470 nm diode laser with commonly used 980 nm diode laser for the adverse 
event and the varicose venous clinical severity scores (VCSS). At early postoperative period 
1470 nm diode laser was superior in both adverse events and VCSSs. (28) 
There is now also experience in patients with recurrent varicosities. Theivacumar et al. (32) 
reported their experience on 104 limbs of 95 patients with recurrent varicose veins. They 
successfully ablated these varicosities and concluded that EVLA was a safe and effective 
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Author Number of limbs Occlusion Rate (%) Follow-up Period 
GSV 
   810 nm 
      Min, 2003 
      Agus, 2006 
  940 nm 
     Ravi, 2006 
     Proebstle, 2003 
  980 nm 
     Gibson, 2007 
     Pannier, 2008 
  1470 nm 
     Pannier, 2009 
     Doganci, 2010 
SSV 
  810 nm 
     Huisman 
  980 nm 
     Desmyttere, 2009 
     Park, 2008 
  1470 nm 
     Doganci, 2011 
 
499 
1076 
 
 
990 
41 
 
210 
67 
 
128 
54 
 
 
169 
 
147 
55 
 
68 
 
93 
97 
 
 
97 
95 
 
96 
88.1 
 
100 
100 
 
 
98 
 
97 
100 
 
100 
 
2 year 
3 years 
 
 
3 years 
6 months 
 
4 months 
2.2 years 
 
1 year 
6 months 
 
 
3 months 
 
1 years 
3 years 
 
6 months 
Table 2. Outcomes following endovenous laver ablation 
option for the treatment of recurrent varicose veins. In our clinical experience between 
February 2010 and February 2011, we treated 46 limbs of 39 patients with recurrent varicose 
veins. Our results are also similar to Theivacumar’s results.  Treatment of recurrent varicosities 
especially in patients with previous surgical stripping is very easy and safe. As a simple rule it 
can be said that “if you cannulate, you can treat any vein” with indication of treatment. 
Due to its anatomic localization treatment of incompetent SSV with endovenous laser 
ablation is superior to surgical stripping. Rashid et al. (7) have shown that ligation of the 
saphenopopliteal junction (SPJ) is not achieved in 30% of the cases, even if the junction is 
marked pre-operatively under ultrasound guidance. In the endovenous laser ablation, there 
is not a problem like that. If there is anatomic SPJ, you can treat the incompetent SSV 
without having any surgical difficulties. As it is summarized in Table 2 the results are very 
promising so far. 
In the review by Van Den Bos et al. (3) success rate of EVLA after a five year period was 
95.4%. Although there are articles with very promising results, there is still a need for 
randomized controlled studies with long term results.  
In our clinical experience (not published yet), we treat 717 patients (1066 limbs) with 1470 
nm diode laser and radial laser fiber between September 2009 and March 2011. There was 
no recanalization so far in this cohort of patients during the follow-up period. 
Results for endovenous treatment of IPVs are not so much as it is in GSVs. Kabnick et al. 
(33) presented data using a 980 nm wavelength. Twenty-five IPVs with an average size of 
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4.4 mm were treated. Closure rate was 85% at a 4 month period. In another study Murphy et 
al. (34) reported 100% closure rate at a 6 months period. 
9. Discussion 
Traditional surgical methods to treat varicose veins are associated with significant 
complications, high recurrence rates and some patient dissatisfaction. In a randomized trial 
of SFJ ligation methods for primary saphenous incompetence, the two year clinical 
recurrence rate was 33% and Doppler ultrasound (DUS) proven recurrence was up to 22%. 
However, the clinical benefits and cost-effectiveness of surgery are well established. (35) 
Minimally invasive techniques such as EVLA are a popular choice for patients and doctors 
because of the low risk of complications, short ‘‘downtime,’’ and excellent cosmetic results. 
When applied properly, these techniques also seem to be effective and safe. For efficacy and 
safety, it is essential that professionals well trained in phlebology and ultrasound 
examination perform these complex procedures, but pain and ecchymoses seem to be 
inherent to all (minimally invasive) procedures of varicose veins including EVLA. (17) 
In recently published studies, high success rates after EVLA have been reported. These have 
been based mainly on duplex US assessment of the treated veins.  
Three recent systematic reviews, two with meta-analysis, have attempted to analyse all of 
the relevant literature comparing surgical outcomes to UGFS, RFA and EVLA, and another 
has compared safety and efficacy of EVLA and surgery. The largest meta-analysis examined 
64 eligible studies, which included over twelve thousand limbs, with DUS findings as 
outcome. Average follow-up was 32 months and estimated pooled success rates at 3 years 
were highest for EVLA with 94%, followed by RFA (84%), surgery (78%) and foam 
sclerotherapy (77%). EVLA was significantly superior to all other methods to abolish 
saphenous incompetence. (3, 35) RFA and UGFS were equally effective as surgery. This 
analysis has had some criticism, as most studies reviewed had not used survival analysis, so 
the success rates are probably inflated. In a separate meta-analysis, the improved 
effectiveness of EVLA is confirmed over surgery, with better post-operative outcomes. 
However venous clinical severity scores (VCSS) were equivalent between EVLA and surgery 
at end of followup. Another systematic review compared safety and efficacy of all treatments, 
new and old, where articles reported comparisons between at least two treatments. This 
review demonstrated better safety records for both EVLA and RFA compared to surgery, 
although major surgical complications were rare. Surgery consistently caused more post-
operative bruising overall and more post-operative pain than both EVLA and RFA. 
Paraesthesia was the most common serious adverse event associated with surgery occurring at 
a median rate of 11.7% (4.1-30.3%) reported among 517 limbs and ten studies. (35) 
In the EVVERT study comparing laser and radiofrequency, 810 nm laser and bare-tip laser 
fibers compared with VNUS ClosureFast catheter. As it is expected in the result part, pain 
scores was lower in the radiofrequency group, and bruising was greater in the laser group. 
(36) However, it is comparison is not well balanced. Simply saying, in this study the authors 
compared the brand new catheter of VNUS (ClosureFast) with the oldest laser technology. 
There is now new generation laser and fiber system commercially in use from a very long 
time. And the conclusion should not be laser generates greater perioperative bruising and 
pain than radiofrequency. Instead, it should be as 810 nm laser and the bare-tip fiber 
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generates greater bruising and pain than radiofrequency. Thus, this study should be 
designed to compare the new generation laser systems (i.e. 1470 nm diode or 1320 Nd:YAG 
lasers and radial laser fibers). In our previous study, 1470 nm diode laser and radial laser 
fibers were compared with 980 nm and bare-tip fibers in randomized controlled groups. We 
found that side effects such as pain, induration (14 vs 3 (radial)), ecchymosis (13 vs 2 
(radial)) and paraesthesia (9 vs 1(radial)) were significantly reduced with the 1470 nm laser 
and radial catheter system compared to the 980 mm bare-tip laser fibre. 
In the review by Van den Bos et al., (3) besides anatomic success rates, patient-reported 
outcomes such as health related quality of life (HRQOL), treatment satisfaction, symptom 
relief, and side effects were analyzed. Compared with surgery, EVLA-treated patients 
appreciated EVLA more than surgery because they reported fewer side effects and their 
HRQOL improved better and faster.  
In our study, patient satisfaction and patient preference were questioned. Most of the 
patients in 1470 nm and radial laser-fiber group replied as “very satisfied-satisfied” and 
“definitely-probably yes”. The difference was statistically significant (p<0.05). Venous 
Clinical Severity Scores also evaluated. VCSSs in the fisrt month were also favorably lower 
in 1470 nm and radial laser fiber group. 
In another study which is similar to ours, Gerard JL et al. (37) questioned “Is bare-tip fiber 
out-dated?” in their study. They used 1470 nm diode laser and compared bare-tip fiber with 
radial fiber. As a conclusion they declared that protected fibers should be recommended as 
bare-tip fibers have proved to be out-dated. 
Laser fibers are evolving with the technological advances. Nowadays after learning the 
importance of fibers, many fibers come-out. Direct vein wall contact of the tip of the fiber 
cause carbonization of the wall. This can induce perforations leading to bruising and pain 
related to white blood cell extravasation. (28) For avoiding direct wall contact of the fiber 
many manufacturers produced alternative fibers such tulip, jacket-tip and radial fibers. 
Another point is the amount of delivered energy. There are many different formulas to 
calculate the amount of energy per centimeter which is known as LEED. As a simple rule a 
minimum of 10 J/cm/diameter is an effective amount. In our experience we generally use 
this formula. 
In our clinical experience, after gaining experience and seeing results of our patients; we 
gradually decreased our watt and LEED levels. At the beginning of our 1470 nm and radial 
fiber experience, we begin with 15 Watts and 90 J/cm LEED level. There was no 
recanalization, and minimal postoperative morbidity. Then we gradually decreased our 
watt level to 12 W and LEED level to 70 J/cm. These parameters are very effective. They do 
not affect the recanalizastion rates. Furthermore our adverse event rate is nearly approach to 
minimum. With these improvements we are now gradually decreasing the amount of 
tumescent local anesthesia.  
These improvements increase the office-based nature of the endovenous laser treatment 
modality. Patients tolerate this procedure well. 
However there is still a need for the long-term results and strong evidences, especially in the 
area of HRQOL and follow-up protocols. There is still an ongoing competition between the 
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endovenous treatment modalities. Recently steam ablation and the mechanochemical 
ablation devices (ClariVein) added to this competition area. The results of these new 
modalities are also beginning to come.  
Evolving Doppler ultrasound technology will also help the physicians to increase their 
success in endovascular techniques by providing excellent diagnostics and perioperative 
imaging options. 
In our opinion next decade will witness the outcome of some other new techniques. Long-
term result of the treatment modalities will be available and by these results strong 
evidences will also be available.  
According to the American Venous Forum Guidelines (4.10.0) recommendation endovenous 
laser therapy of GSV is safe and effective and has a grade 1A recommendation level. 
Recommendation for the IPV (4.21.0) has a lower evidence level and is grade 2C. (8, 22) 
10. Summary 
Endovenous laser ablation is a safe and effective treatment modality in the treatment of 
incompetent great and small saphenous veins. With an obsessive approach to all technical 
steps and patient selection criterion, incidence of adverse events and complication is very 
low. Although we still need long-term result and strong evidences longer wavelengths and 
new generation laser fibers seem superior to the shorter wavelengths and bare-tip fibers. 
Multicenter randomized controlled trials with larger patient volume and standard long-
term follow-up protocols are still needed to answer our questions. 
However, with the available results and patient/physician preferences it can be said that 
conventional high ligation plus stripping of the incompetent saphenous veins is no longer 
the gold standard treatment choise. 
In the very near future, reticular veins, incompetent tributary veins, perforator veins beside 
main trunk varicosities will be treated by endovenous modalities and the patiens will have 
the opportunity to have these procedures in best cosmetic and the least invasive ways 
without having stab incisions. 
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